• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Engineered Dex: A promising therapeutic strategy for oral squamous cell carcinoma.

作者信息

Vijayashree Priyadharsini J, Abilasha R, Anitha P, Paramasivam A

机构信息

Clinical Genetics Lab, Centre for Cellular and Molecular Research, Saveetha Dental College & Hospital, Saveetha Institute of Medical and Technical Sciences [SIMATS], Saveetha University, Chennai, India.

Department of Oral Pathology, Saveetha Dental College & Hospital, Saveetha Institute of Medical and Technical Sciences [SIMATS], Saveetha University, Chennai, India.

出版信息

J Stomatol Oral Maxillofac Surg. 2023 Feb;124(1):101277. doi: 10.1016/j.jormas.2022.08.020. Epub 2022 Sep 1.

DOI:10.1016/j.jormas.2022.08.020
PMID:36058533
Abstract
摘要

相似文献

1
Engineered Dex: A promising therapeutic strategy for oral squamous cell carcinoma.工程化右旋糖酐：口腔鳞状细胞癌的一种有前景的治疗策略。
J Stomatol Oral Maxillofac Surg. 2023 Feb;124(1):101277. doi: 10.1016/j.jormas.2022.08.020. Epub 2022 Sep 1.
2
Engineered exoASO-STAT6: a potent monotherapy for oral squamous cell carcinoma.工程化外泌体反义寡核苷酸-信号转导和转录激活因子6：口腔鳞状细胞癌的有效单一疗法
Future Oncol. 2022 Aug;18(25):2767-2769. doi: 10.2217/fon-2022-0496. Epub 2022 Jun 29.
3
Chronotherapeutics in the management of oral squamous cell carcinoma - A futuristic novel treatment strategy.口腔鳞状细胞癌管理中的时辰治疗学——一种未来主义的新型治疗策略。
Indian J Cancer. 2023 Oct 1;60(4):595-596. doi: 10.4103/ijc.ijc_19_23. Epub 2024 Jan 4.
4
Marine bioactive compounds as potential therapeutic inhibitor for oral squamous cell carcinoma (OSCC).海洋生物活性化合物作为口腔鳞状细胞癌（OSCC）的潜在治疗抑制剂
Oral Oncol. 2022 Aug;131:105971. doi: 10.1016/j.oraloncology.2022.105971. Epub 2022 Jun 15.
5
MicroRNA-138 and its targets: A therapeutic molecule for oral squamous cell carcinoma.微小RNA-138及其靶点：一种用于口腔鳞状细胞癌的治疗分子。
Oral Oncol. 2022 Jul;130:105925. doi: 10.1016/j.oraloncology.2022.105925. Epub 2022 May 21.
6
Engineered therapeutic bacteria for the treatment of oral squamous cell carcinoma.
Oral Oncol. 2022 Jul;130:105874. doi: 10.1016/j.oraloncology.2022.105874. Epub 2022 May 6.
7
Squamous cell carcinomas of the tongue and oral cavity as secondary malignancies: what factors are implicated?舌和口腔鳞状细胞癌作为继发性恶性肿瘤：涉及哪些因素？
Oncologist. 2013;18(3):245-7. doi: 10.1634/theoncologist.2013-0021. Epub 2013 Mar 13.
8
Considerations regarding the tumor-suppressor role of naringenin as a novel agent for the treatment of oral squamous cell carcinoma.关于柚皮素作为治疗口腔鳞状细胞癌的新型药物的肿瘤抑制作用的考量。
Cancer Immunol Immunother. 2023 Sep;72(9):3133-3134. doi: 10.1007/s00262-023-03452-0. Epub 2023 May 6.
9
Mitophagy: A therapeutic target for oral squamous cell carcinoma.
Oral Oncol. 2022 Jun;129:105881. doi: 10.1016/j.oraloncology.2022.105881. Epub 2022 Apr 30.
10
Comment on circulatory miRNAs as therapeutic molecules for oral potentially malignant disorder and oral squamous cell carcinoma.关于循环微小RNA作为口腔潜在恶性疾病和口腔鳞状细胞癌治疗分子的评论。
Oral Oncol. 2022 Jul;130:105901. doi: 10.1016/j.oraloncology.2022.105901. Epub 2022 May 6.